41 – 50 of 142
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Systemic administration of Neuregulin-1ß(1) protects dopaminergic neurons in a mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
(
- Contribution to journal › Article
-
Mark
The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity
(
- Contribution to journal › Article
- 2010
-
Mark
Neural grafting in Parkinson's disease: unraveling the mechanisms underlying graft-induced dyskinesia
(
- Contribution to journal › Scientific review
-
Mark
Modeling pathophysiological aspects of Parkinson’s disease: Manipulating DA handling and alpha-synuclein expression in the nigrostriatal pathway using viral vectors
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Neurochemical measures co-vary with personality traits: Forensic psychiatric findings replicated in a general population sample
(
- Contribution to journal › Article
-
Mark
No effect of obstetric complications on basal ganglia volumes in schizophrenia
(
- Contribution to journal › Scientific review
-
Mark
Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and monoamine metabolite concentrations in cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
Dyskinesia - Advances in the understanding of pathophysiology and possible treatment options
(
- Contribution to journal › Article